RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제
      • 좁혀본 항목 보기순서

        • 원문유무
        • 원문제공처
        • 등재정보
        • 학술지명
        • 주제분류
        • 발행연도
        • 저자
          펼치기

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • SCOPUSKCI등재

        케토롤락트로메타민 서방성 펠렛의 약물속도론적 평가

        곽손혁(Son Hyok Kwak),황성주(Sung Joo Hwang),장혁,남경완(Kyung Wan Nam),문영걸(Young Girl Moon),이해방(Hai Bang Lee),조선행(Sun Hang Cho),육순홍(Sun Hong Yuk),이한구(Han Koo Lee),정상영(Sang Young Jeong),이영원(Young Won Lee) 한국약제학회 2000 Journal of Pharmaceutical Investigation Vol.30 No.4

        To develop a sustained-release preparation containing ketorolac tromethamine, two sustained-release pellet formulations were evaluated with a pharmacokinetic study as compared with a conventional commercial tablets (10 ㎎ Tarasyn^(TM), Roche Korea Ltd.). Two sustained-release formulations were as follows; formulation A was composed of an inner layer containing 75% of drug coated with Eudragit^(TM) RS 100 membrane and an outer layer containing 25% of drug mixed with Eudragit^(TM) NE30D, and formulation B was composed of only an inner layer containing 100% of drug coated with Eudradit^(TM) RS 100 membrane. The dissolution test was performed for two formulations. In case of conventional tablets, 2.5 ㎎ of drug per a dose was administered orally into male Albino rabbit (2.0-2.3 ㎏ of body weight) 3 times at intervals of 4 hours. In case of two sustained formulations, 7.5 ㎎ of drug was administered once orally. Blood samples were withdrawn periodically after the administration, and the blood concentration was determined by HPLC. The conventional tablets showed very high peak-trough fluctuation between administered doses, but two sustained formulations showed less fluctuation. Formulation A with the loading dose showed the time to reach minimum effective concentration (MEC) i.e. the onset time was less than 20 min, while Formulation B had more than 1 hr of the onset time. Formulation A had the more constant plasma level than formulation B. However, formulation B had a time lag, so the plasma level was less than MEC for an initial period of 1 hr. In formulation A, the plasma level was maintained within the therapeutic window (0.3-5 ㎍/㎖) for a long period. Formulation A was thought to be an ideal sustained-release formulation for ketorolac tromethamine oral delivery system.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼